Switch theme
Sign up to access all valuation multiples
Narayana Hrudayalaya Ltd is an India-based medical and healthcare service provider. It operates a chain of multispecialty, tertiary healthcare facilities. The hospital offers medical services in the field of dermatology, hematology, neurology, orthopedics, pediatrics, cancer care, cardiology, pulmonology. The Company’s sole operating segment is Medical and Healthcare Related Services. It also provides surgery services such as Cardiac Surgery, Neurosurgery, Thoracic Surgery, Renal Transplant, and others. Imaging and radiology services, Physiotherapy sessions, and blood bank services are some of the diagnostics and support provided by the hospital. It has business operations in India and the Rest of the world, of which maximum revenue is generated from the business operations in India.
2000
11.7K+
LTM Revenue $658M
LTM EBITDA $152M
$4.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Narayana Health has a last 12-month revenue (LTM) of $658M and a last 12-month EBITDA of $152M.
In the most recent fiscal year, Narayana Health achieved revenue of $642M and an EBITDA of $159M.
Narayana Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Narayana Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $658M | XXX | $642M | XXX | XXX | XXX |
| Gross Profit | $521M | XXX | $400M | XXX | XXX | XXX |
| Gross Margin | 79% | XXX | 62% | XXX | XXX | XXX |
| EBITDA | $152M | XXX | $159M | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 25% | XXX | XXX | XXX |
| EBIT | $123M | XXX | $117M | XXX | XXX | XXX |
| EBIT Margin | 19% | XXX | 18% | XXX | XXX | XXX |
| Net Profit | $95.5M | XXX | $92.5M | XXX | XXX | XXX |
| Net Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $206M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Narayana Health's stock price is INR 1744 (or $20).
Narayana Health has current market cap of INR 354B (or $4.1B), and EV of INR 361B (or $4.2B).
See Narayana Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.2B | $4.1B | XXX | XXX | XXX | XXX | $0.47 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Narayana Health has market cap of $4.1B and EV of $4.2B.
Narayana Health's trades at 6.7x EV/Revenue multiple, and 27.2x EV/EBITDA.
Equity research analysts estimate Narayana Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Narayana Health has a P/E ratio of 43.4x.
See valuation multiples for Narayana Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4.1B | XXX | $4.1B | XXX | XXX | XXX |
| EV (current) | $4.2B | XXX | $4.2B | XXX | XXX | XXX |
| EV/Revenue | 6.4x | XXX | 6.7x | XXX | XXX | XXX |
| EV/EBITDA | 27.8x | XXX | 27.2x | XXX | XXX | XXX |
| EV/EBIT | 34.5x | XXX | 36.7x | XXX | XXX | XXX |
| EV/Gross Profit | 8.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 43.4x | XXX | 44.8x | XXX | XXX | XXX |
| EV/FCF | -465.3x | XXX | -749.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNarayana Health's last 12 month revenue growth is 14%
Narayana Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $24K for the same period.
Narayana Health's rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Narayana Health's rule of X is 58% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Narayana Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 25% | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | 11% | XXX | XXX | XXX |
| Rule of 40 | 39% | XXX | 39% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 58% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $24K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 44% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Narayana Health acquired XXX companies to date.
Last acquisition by Narayana Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Narayana Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Narayana Health founded? | Narayana Health was founded in 2000. |
| Where is Narayana Health headquartered? | Narayana Health is headquartered in India. |
| How many employees does Narayana Health have? | As of today, Narayana Health has 11.7K+ employees. |
| Who is the CEO of Narayana Health? | Narayana Health's CEO is Dr. Emmanuel Rupert. |
| Is Narayana Health publicy listed? | Yes, Narayana Health is a public company listed on NSE. |
| What is the stock symbol of Narayana Health? | Narayana Health trades under NH ticker. |
| When did Narayana Health go public? | Narayana Health went public in 2016. |
| Who are competitors of Narayana Health? | Similar companies to Narayana Health include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Narayana Health? | Narayana Health's current market cap is $4.1B |
| What is the current revenue of Narayana Health? | Narayana Health's last 12 months revenue is $658M. |
| What is the current revenue growth of Narayana Health? | Narayana Health revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Narayana Health? | Current revenue multiple of Narayana Health is 6.4x. |
| Is Narayana Health profitable? | Yes, Narayana Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Narayana Health? | Narayana Health's last 12 months EBITDA is $152M. |
| What is Narayana Health's EBITDA margin? | Narayana Health's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Narayana Health? | Current EBITDA multiple of Narayana Health is 27.8x. |
| What is the current FCF of Narayana Health? | Narayana Health's last 12 months FCF is -$9.1M. |
| What is Narayana Health's FCF margin? | Narayana Health's last 12 months FCF margin is -1%. |
| What is the current EV/FCF multiple of Narayana Health? | Current FCF multiple of Narayana Health is -465.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
